Clinical Trials Projects
This project evaluated a randomized, placebo-controlled Phase 3 clinical trial investigating the effects of high-dose liraglutide (3 mg) on weight loss, body composition, and hormonal and metabolic outcomes in non-diabetic women with obesity and polycystic ovary syndrome (PCOS). Our analysis found that liraglutide led to significantly greater weight loss, improved insulin sensitivity, and reduced androgen excess compared to placebo, highlighting its potential as an effective adjunct therapy for PCOS management. Through this review, we strengthened our ability to critically assess clinical trial design, interpret outcomes, and evaluate the quality and limitations of biomedical research. Read more here…. View Infographic here…
Citation: Shiqiong Lu, Cinthia Flores, Carolina Rios Rocha, Hodalo Yao Poudima, Faye O’Brien (2021, September 20). Greater Awareness and Knowledge of Clinical Research Increases Willingness to Participate in Future Vaccine Trials- An Examination of the Enduring Impact of COVID-19 Pandemic. Corpus Journal of Clinical Trails, 2(1).
Citation: Faye S. O’Brien, David L. Waldrop, Ebonie I. Gadson, Henry Rice, Norman M. Goldfarb (2020, September). The Enduring Impact of COVID-19 on Current and Future Clinical Trials. Journal of Clinical Research Best Practices, 16(9).